Loading...
XKRX023960
Market cap33mUSD
Jan 10, Last price  
1,416.00KRW
1D
0.14%
1Q
-25.59%
Jan 2017
-40.13%
Name

SC Engineering Co Ltd

Chart & Performance

D1W1MN
XKRX:023960 chart
P/E
—
P/S
0.37
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
6.46%
Rev. gr., 5y
-11.52%
Revenues
135.98b
-0.91%
228,260,754,000379,218,094,000318,260,091,000282,801,112,000309,382,937,260318,810,977,900254,339,137,570250,358,393,910410,707,049,280310,315,230,590251,692,538,290250,825,145,400240,133,541,11072,469,645,41075,724,704,650137,224,812,690135,981,756,850
Net income
-2.36b
L
4,846,356,0007,183,500,0005,455,238,0001,133,037,000-7,334,505,000-3,943,054,240-9,375,604,510-18,119,279,0002,266,787,230-14,999,369,000-8,577,870,000-253,809,750-4,376,261,900-10,136,416,350-7,010,941,9905,369,963,200-2,364,589,340
CFO
-2.99b
L
15,987,985,000-46,346,394,00053,382,943,00016,903,371,000358,123,330-24,653,175,44022,202,411,260-8,679,486,650-11,295,012,2101,630,594,54016,045,209,76030,793,582,950-44,857,138,88018,517,163,2405,799,822,6807,652,883,330-2,991,518,619
Dividend
Dec 27, 201350 KRW/sh

Profile

SC Engineering Co., Ltd., together with its subsidiaries, engages in the plant, hydraulic, bio, and engineering businesses in South Korea, rest of Asia, the Middle East, the United States, and Europe. The company designs, manufactures, and sells chemical plant facilities; manufactures and sells hydraulic equipment; manufactures, imports, exports, and sells biological products using cell culture; and designs, engineers, manufactures, and sells air-cooled heat exchangers. It also offers umbilical cord blood storage products; glass lining equipment and centrifuges; and supplies cosmetic products. The company was formerly known as Sewoncellontech Co., Ltd. and changed its name to SC Engineering Co., Ltd. in 2006. SC Engineering Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea.
URL
sc-eng.com
IPO date
Jun 23, 1997
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
135,981,757
-0.91%
137,224,813
81.22%
Cost of revenue
126,499,392
120,708,588
Unusual Expense (Income)
NOPBT
9,482,365
16,516,225
NOPBT Margin
6.97%
12.04%
Operating Taxes
562,950
829,140
Tax Rate
5.94%
5.02%
NOPAT
8,919,415
15,687,085
Net income
(2,364,589)
-144.03%
5,369,963
-176.59%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
9,080,169
10,499,761
Long-term debt
6,887,267
9,656,110
Deferred revenue
4,217,412
3,532,700
Other long-term liabilities
503,433
229,428
Net debt
(4,888,667)
(5,189,892)
Cash flow
Cash from operating activities
(2,991,519)
7,652,883
CAPEX
(5,415,658)
(7,212,701)
Cash from investing activities
1,413,463
1,410,877
Cash from financing activities
(542,822)
(6,160,672)
FCF
5,888,899
27,052,766
Balance
Cash
12,303,389
19,939,901
Long term investments
8,552,713
5,405,862
Excess cash
14,057,015
18,484,523
Stockholders' equity
(14,412,866)
953,338
Invested Capital
73,240,363
61,030,335
ROIC
13.29%
26.06%
ROCE
16.04%
26.50%
EV
Common stock shares outstanding
31,549
31,194
Price
1,739.00
9.03%
1,595.00
-46.74%
Market cap
54,863,721
10.27%
49,754,175
-42.14%
EV
49,975,054
44,564,283
EBITDA
11,120,238
18,550,443
EV/EBITDA
4.49
2.40
Interest
1,019,539
1,623,983
Interest/NOPBT
10.75%
9.83%